Previous studies have shown that YTHDF1 [39], YTHDF2 [39], IMP2 [40, 41] and hnRNPA2B1 [42] are highly expressed in gliomas, while hnRNPC [39] is poorly expressed in gliomas. The gene discussed is YTHDF2; the disease is central nervous system cancer.